BUY Pfizer Limited — Bernstein
byBernsteinHorizon: NA (inferred 1 year)5 Nov 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·4 Nov · 3d ago
Pfizer Q2 Results: Stock up 5% after net profit jumps 66% on ₹132 crore one-time gain
NewsCnbc-Tv18·3 Nov · 4d ago
Pfizer Q2 Results: Net Profit Jumps 66% To Rs 313 Crore Boosted By One-Time Gain; Revenue Up 14% YoY
NewsNdtv-Profit·3 Nov · 4d ago
Pfizer Ltd reported unaudited financial results for the quarter ended September 30, 2026, including an exceptional gain of Rs 132.06 crore from a lump sum payment related to the discontinuation of Min
BSE · Board Meeting·3 Nov · 4d ago
Pfizer Limited reported financial results for the quarter ended September 30, 2026, including an exceptional gain of 132.06 crore from a lump sum payment related to the discontinuation of Minipress XL
NSE · Outcome of Board Meeting·3 Nov · 4d ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Pfizer
- BUY — ICICI Securities4 Nov 2026 · ~1 year · target ₹4,800 · Active
- BUY — Aastha Jain, Hem Securities20 Aug 2026 · Same day · target ₹5,015 · Expired
- BUY — Shrikant Chouhan, Kotak Securities19 Aug 2026 · ~2 weeks · target ₹5,200 · SL hit
- BUY — Sahi Research19 Aug 2026 · ~2 weeks · target ₹5,050 · SL hit
- BUY — VLA Ambala13 Aug 2026 · ~2 weeks · target ₹6,000 · Expired
More from Bernstein
- BUY Titan Company6 Nov 2026 · ~1 year · target ₹5,400 · Active
- SELL BSE5 Nov 2026 · ~1 year · target ₹3,180 · Active
- BUY GlaxoSmithKline Pharmaceuticals5 Nov 2026 · ~1 year · target ₹3,430 · Active
- BUY Devyani International3 Nov 2026 · ~1 year · target ₹160 · Active
- BUY Laurus Labs30 Oct 2026 · ~1 year · target ₹3,500 · Active

